glp 1 gas and bloating GLP-1 Intolerance Endoscopic Sleeve Options Managing Gas and Other Digestive

Gastrointestinal adverse events leading to treatment discontinuation occur in approximately 4-5% of patients on Wegovy, with diarrhea being one contributing factor

GES improves nausea, vomiting, quality of life and nutritional status in patients with refractory DGp [133,134,135,136]

Maintain adequate fluid intake to prevent dehydration, particularly during the initial weeks when gastrointestinal side effects are most prominent

Retatrutide, based on available data, pushes that above 80% as well

American journal of physiology Endocrinology and metabolism

But many report no noticeable results, along with frustrating experiences around product quality and customer service